ThermoProfen™ (Matrix Transdermal Ketoprofen/CHADD™ System)
DrugTransdermal patch applied to the knee for 12 hours daily.
Other names: Matrix Transdermal Ketoprofen CHADD System
NCT Number: NCT00488267
ThermoProfen is a transdermal ketoprofen patch that is integrated with a long-lasting CHADD (Controlled Heat-Assisted Drug Delivery) unit for the treatment of chronic pain associated with osteoarthritis. This study will evaluate ThermoProfen for the treatment of mild to moderate pain associated with osteoarthritis of the knee in adults.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Phase 3
Peoria, Arizona, United States
The primary objective of the study is to compare the efficacy of ThermoProfen™ against two other experimental treatments.
The treatment may be ThermoProfen (Matrix Transdermal Ketoprofen Patch) or a patch that may or may not include ketoprofen and that may or may not provide heat.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Transdermal patch applied to the knee for 12 hours daily.
Other names: Matrix Transdermal Ketoprofen CHADD System
Transdermal patch applied to the knee for 12 hours daily.
Other names: Placebo patch with heating system
Transdermal knee applied to the knee for 12 hours daily.
Other names: ketoprofen matrix with no heat
Time frame: 12 weeks
Time frame: 12 weeks
ZARS Pharma Inc.
Industry
A Randomized, Double-Blind, 12-Week Study to Evaluate the Efficacy of ThermoProfen™ in the Treatment of Patients With Mild to Moderate Pain Associated With Osteoarthritis of the Knee (ZMK-301)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07710404
Arthritis, Joint Diseases
Faisalābad, Punjab Province, Pakistan
View Trial DetailsNCT02628314
Arthritis, Joint Diseases
Winston-Salem, North Carolina, United States
View Trial DetailsNCT03083548
Arthritis, Image, Body
Oslo, Norway
View Trial DetailsNCT02289716
Arthritis, Joint Diseases
El Cajon, California, United States
View Trial Details